Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yili Lu

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
NPJ Biofilms and Microbiomes|April 6, 2026
Biofilms reshape soil-water dynamics with enhanced vapor adsorption and hysteresis reversal under dry conditionsHuan Hu, Chong Chen, Yili Lu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2002
Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal womenSusan M Ott, Anna Oleksik, Yili Lu, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 8, 2024
Changes in serum bone turnover markers and bone mineral density Z-score in children with osteogenesis imperfecta after zoledronic acid treatmentJiahui Jin, Luo Yue, Yili Lu, et al.
Depression and Anxiety|September 10, 2003
Duloxetine in treatment of anxiety symptoms associated with depressionDavid L Dunner, David J Goldstein, Craig Mallinckrodt, et al.
Pain|June 2, 2005
Duloxetine vs. placebo in patients with painful diabetic neuropathyDavid J Goldstein, Yili Lu, Michael J Detke, et al.
Heliyon|March 25, 2024
Novel homozygous mutations in <i>AIRE</i> leading to APS-1 and potential mechanisms based on bioinformatics analysisHuiping Wu, Yiqi Mo, Shiwen Yu, et al.
Journal of Psychiatric Research|October 24, 2002
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depressionMichael J Detke, Yili Lu, David J Goldstein, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trialMichael J Detke, Yili Lu, David J Goldstein, et al.
Psychosomatics|January 8, 2004
Effects of duloxetine on painful physical symptoms associated with depressionDavid J Goldstein, Yili Lu, Michael J Detke, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosisOlof Johnell, Wim H Scheele, Yili Lu, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
NPJ Biofilms and Microbiomes|April 6, 2026
Biofilms reshape soil-water dynamics with enhanced vapor adsorption and hysteresis reversal under dry conditionsHuan Hu, Chong Chen, Yili Lu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2002
Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal womenSusan M Ott, Anna Oleksik, Yili Lu, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 8, 2024
Changes in serum bone turnover markers and bone mineral density Z-score in children with osteogenesis imperfecta after zoledronic acid treatmentJiahui Jin, Luo Yue, Yili Lu, et al.
Depression and Anxiety|September 10, 2003
Duloxetine in treatment of anxiety symptoms associated with depressionDavid L Dunner, David J Goldstein, Craig Mallinckrodt, et al.
Pain|June 2, 2005
Duloxetine vs. placebo in patients with painful diabetic neuropathyDavid J Goldstein, Yili Lu, Michael J Detke, et al.
Heliyon|March 25, 2024
Novel homozygous mutations in <i>AIRE</i> leading to APS-1 and potential mechanisms based on bioinformatics analysisHuiping Wu, Yiqi Mo, Shiwen Yu, et al.
Journal of Psychiatric Research|October 24, 2002
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depressionMichael J Detke, Yili Lu, David J Goldstein, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trialMichael J Detke, Yili Lu, David J Goldstein, et al.
Psychosomatics|January 8, 2004
Effects of duloxetine on painful physical symptoms associated with depressionDavid J Goldstein, Yili Lu, Michael J Detke, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosisOlof Johnell, Wim H Scheele, Yili Lu, et al.
Pageof 4